A
ISSUER//CIK 0001572552
Asterias Biotherapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A98.2 KBAsterias Biotherapeutics, Inc.Mar 12, 4:50 PM ET·0000919574-19-002300
- SC 13D/A47.6 KBAsterias Biotherapeutics, Inc.Mar 11, 7:07 PM ET·0001493152-19-003107
- 8-K236.2 KBAsterias Biotherapeutics, Inc.Mar 8, 4:05 PM ET·0001493152-19-003027
- 8-K485.1 KBAsterias Biotherapeutics, Inc.Mar 1, 4:32 PM ET·0001140361-19-004236
- 10-Q3.8 MBAsterias Biotherapeutics, Inc.Nov 9, 4:01 PM ET·0001140361-18-042844
- SC 13D/A53.3 KBAsterias Biotherapeutics, Inc.Nov 8, 5:13 PM ET·0001493152-18-015487
- 8-K1.0 MBAsterias Biotherapeutics, Inc.Nov 8, 6:47 AM ET·0001140361-18-042682
- 8-K23.5 KBAsterias Biotherapeutics, Inc.Oct 1, 4:06 PM ET·0001140361-18-039753
- 8-K17.1 KBAsterias Biotherapeutics, Inc.Sep 18, 4:06 PM ET·0001140361-18-038643
- 10-Q3.1 MBAsterias Biotherapeutics, Inc.Aug 9, 4:51 PM ET·0001140361-18-036076
Insiders
10- Arno AndrewDirector
- BAILEY DON MDirector
- Bradsher Neal CSee Remarks Section
- BROADWOOD CAPITAL INCSee Remarks Section
- BROADWOOD PARTNERS, L.P.See Remarks Section
- Cartt Stephen LaHueDirector
- Chavez Ryan DanielCFO and General Counsel
- GERON CORP10% Owner
- LEBKOWSKI JANEChief Scientific Officer
- LeBuhn Richard T.Director
Tickers
No tickers on record
Addresses
business
6300 DUMBARTON CIRCLE
FREMONT, CA, 94555
mailing
6300 DUMBARTON CIRCLE
FREMONT, CA, 94555